phone icon303-444-6950 | 301-913-0213
divider

miRagen Therapeutics


Website: http://www.miragentherapeutics.com

Type of Company: Life Sciences

Company Status: Active

Business:
miRagen Therapeutics is developing innovative microRNA-based therapeutics for cardiovascular and muscle disease.
Outcome:
IPO (NASDAQ:MGEN) February, 2017.
Co-investors:
Atlas Venture, Amgen Ventures, Broadview Ventures, Remeditex Ventures